Part 1 of the stocks that moved on the previous day include Eyes, Rincers, Carlet HD, etc.

Stock name <code> 27 closing price ⇒ SigmaXis <6088> 1565 +40. Announced a share buyback of up to 0.91% of the outstanding shares and a cancellation of 1.13% of the outstanding shares, with a limit of 400,000 shares. Acquired 288,000 shares today. Ips <4390> 2192 +95 won an order for an online document management system from Quezon City, Philippines. Sekichu <9976> 1253 -32 operating profit in the first quarter decreased by 25.0%. PayCloud <4015> 516 +33.

Fisco JapanJun 28 06:15

Esraline G, Carlet HD, and Daiyuuki are among them.

<6856> Horiba Manufacturing Co., Ltd. rose sharply by 265 to 12,330. There were factory tours and IR Day held the previous day, which seem to have led to evaluation materials. As for the semiconductor situation, it seems that the market for mass flow controllers has improved, and a recovery is expected for the second half of the year. Sales to China also seem to be performing well in the semiconductor-related field and exceed expectations. In addition, there is a growing expectation for future growth in the hydrogen-related field and the life science field, etc. <3903> g

Fisco JapanJun 27 14:18

Active and newly listed stocks during the morning session.

*Carrit HD<4275>1420+123 is recommended for new purchase by Tokai Tokyo Securities. *Osaka Organic Chemical Industry<4187>3925+340 has upwardly revised its performance and dividend forecast. *Akebono Brake Industry<7238> 179+10 continues to be seen as a good material for borrowing refinancing funds. *Tei Gaia<3738> 3090+122 is expected to continue to be involved in restructuring speculation. *Horiba Seisakusho<6856> 12605+540 held an IR Day the previous day.

Fisco JapanJun 27 12:55

Hot stocks digest (morning session): Carritt HD, Dai Organic Chemical, Technologies, etc.

Nexera <4565>: 1,653 yen (+48 yen), a significant increase. It has announced that it has achieved an important milestone in the research stage of drug discovery partnership with Abbvie for multiple targets in neurological diseases. As a result, it will receive $10 million, most of which will be recognized as revenue in 2024 and the rest after 2025. Achieving the first milestone in drug discovery partnership is expected to lead to further progress in the project in the future.

Fisco JapanJun 27 10:40

Volume change rate ranking (9:00) - Astena HD, Ichigo GR, etc. ranked in.

* In the volume change rate ranking, by comparing the average volume over the past five days with the volume on the day of delivery, you can understand the interests of market participants such as search trends. * Top volume change rate as of June 27th 9:32 AM (compared to the average volume of the past five days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <5283> Takamizawa 56,300 107,185.08 329.77% -0.023

Fisco JapanJun 27 08:54

Asthena HD has ranked in and revised its financial estimates for the November 24th fiscal year upward.

Astenahd <8095> ranks in (as of 9:32 am). Significantly continued growth. After the end of the previous trading day, the financial estimates for the 24th year of November have been revised upward, becoming a buying point. Operating profit is expected to be 1.6 billion yen (+41.9% YoY). It has been raised by about 39% from the previous estimate, as some drug prices have risen due to revisions and import cosmetics sales are doing well. Top change rate of trade volume [as of June 27 09:32] (latest 5).

Fisco JapanJun 27 08:37